Company Performance Metrics
David Doyle: Co-Founder and COO- Janusz Sowadski: Founder and Chief Science Officer
DNA SEQ provides reports that match the patient's genomic profile to targeted therapies using unique crystallography based filtering methodology.
Unique technology alliance that has developed a machine learning algorithm based on structural genomics leveraging crystallography and our proprietary crystal structures library, to match
genomics of cancer patients with available targeted oncology drugs.
Our predictive personalized medicine approach helps physicians make treatment decisions for cancer patients by identifying the molecular growth drivers of the cancer, and matching them to relevant targeted therapeutic options.
NGS of the entire exome verse just panels because each patient’s resistance is different.
Research reports that help physicians make treatment decisions for cancer patients by identifying the molecular growth drivers of the cancer, and matching them to relevant targeted therapeutic options.
